Estimating the health benefits and cost-savings of a cap on the size of single serve sugar-sweetened beverages.


Journal

Preventive medicine
ISSN: 1096-0260
Titre abrégé: Prev Med
Pays: United States
ID NLM: 0322116

Informations de publication

Date de publication:
03 2019
Historique:
received: 24 08 2018
revised: 20 12 2018
accepted: 15 01 2019
pubmed: 21 1 2019
medline: 17 4 2020
entrez: 21 1 2019
Statut: ppublish

Résumé

Sugar-sweetened beverage (SSB) intake is associated with tooth decay, obesity and diabetes. We aimed to model the health and cost impact of reducing the serving size of all single serve SSB to a maximum of 250 ml in New Zealand. A 250 ml serving size cap was modeled for all instances of single serves (<600 ml) of sugar-sweetened carbonated soft drinks, fruit drinks, carbonated energy drinks, and sports drinks in the New Zealand National Nutrition Survey intake data (2008/09). A multi-state life-table model used the change in energy intake and therefore BMI to predict the resulting health gains in quality-adjusted life-years (QALYs) and health system costs over the remaining life course of the New Zealand population alive in 2011 (N = 4.4 million, 3% discounting). The 'base case' model (no compensation for reduced energy intake) resulted in an average reduction in SSB and energy intake of 23 ml and 44 kJ (11 kcal) per day or 0.22 kg of weight modeled over two years. The total health gain and cost-savings were 82,100 QALYs (95% UI: 65100 to 101,000) and NZ$1.65 billion [b] (95% UI: 1.19 b to 2.24 b, (US$1.10 b)) over the lifespan of the cohort. QALY gains increased to 116,000 when the SSB definition was widened to include fruit juices and sweetened milks. A cap on single serve SSB could be an effective part of a suite of obesity prevention and sugar reduction interventions in high income countries.

Identifiants

pubmed: 30660706
pii: S0091-7435(19)30013-1
doi: 10.1016/j.ypmed.2019.01.009
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

150-156

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Christine Cleghorn (C)

Burden of Disease Epidemiology, Equity and Cost-Effectiveness Programme, University of Otago, Wellington, New Zealand. Electronic address: Cristina.cleghorn@otago.ac.nz.

Tony Blakely (T)

Burden of Disease Epidemiology, Equity and Cost-Effectiveness Programme, University of Otago, Wellington, New Zealand. Electronic address: tony.blakely@otago.ac.nz.

Cliona Ni Mhurchu (CN)

National Institute for Health Innovation, University of Auckland, Auckland, New Zealand. Electronic address: c.nimhurchu@auckland.ac.nz.

Nick Wilson (N)

Burden of Disease Epidemiology, Equity and Cost-Effectiveness Programme, University of Otago, Wellington, New Zealand. Electronic address: nick.wilson@otago.ac.nz.

Bruce Neal (B)

The George Institute for Global Health, University of New South Wales, Faculty of Medicine, Sydney, Australia; Imperial College London, London, UK. Electronic address: bneal@georgeinstitute.org.au.

Helen Eyles (H)

National Institute for Health Innovation, University of Auckland, Auckland, New Zealand. Electronic address: h.eyles@auckland.ac.nz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH